Note: Ingredients listed on restricted chemical lists
EC/CAS
99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
N/A
EC/CAS
202-785-7
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
N/A
General Information
Revision date
2010-05-21
Product name
DETOGESIC; EQUIMIDINE
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Appearance: Clear aqueous solution
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term: May be toxic if swallowed. May be absorbed through mucous membranes and cause systemic effects. May cause eye irritation. May cause skin irritation. May cause allergic skin reaction (based on components) . Known Clinical Effects: This material is an alpha-2 adrenergic receptor agonist intended for animal use only. Symptoms reported after accidental human exposure have included drowsiness, decrease in blood pressure (hypotension), increase in blood pressure (hypertension), decreased heart rate (bradycardia), tingling sensation, numbness, pain, headache, sleepiness (somnolence), dilated pupils, and vomiting. A higher rate of congenital limb deficiencies have been seen in women taking this drug. EU Indication of danger: Not classified Australian Hazard Classification Non-Hazardous Substance. Non-Dangerous Goods. (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
